Andrew Payne

Andrew is a senior associate in the intellectual property team and provides advice on contentious and non-contentious patent issues. He has a particular interest in advising life sciences companies, following a previous career as a medicinal chemist in the pharmaceutical industry.

显示完整简历隐藏完整简历

职业发展

Since 2020	Senior Associate, Taylor Wessing
2015 - 2020	Associate, Taylor Wessing
2013 - 2015	Trainee Solicitor , CMS Cameron McKenna

2009 - 2013	Group Leader, Medicinal Chemistry at Eisai
2000 - 2009	Team Leader, GlaxoSmithKline
1998 - 1999	Postdoctoral Researcher, The University of Texas at Austin

更多更少

教育

2015	Admitted as a lawyer, England & Wales
2013	LPC distinction, BPP Law School
2011	GDL commendation, BPP Law School, London

1997	PhD in synthetic organic chemistry from Imperial College, London
1994	BSc Hons Chemistry, Imperial College and Università degli Studi di Firenze, Italy

更多更少

Publications

Declaratory Relief in the English Patents Court, Bio-Science Law Review, 2016, p 123-128
Patents Overhauled: Impact of the America Invents Act on the Pharmaceutical Industry (co-author), European Biopharmaceutical Review, Spring 2015
New and Approved: The New EU Clinical Trials Regulation (co-author), European Pharmaceutical Contractor, December 2014 p 50-53